| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/01/2002 | WO2002012227A3 Indole, azaindole and indazole derivatives having vegf inhibiting activity |
| 08/01/2002 | WO2002012190A3 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 08/01/2002 | WO2002011766A3 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation |
| 08/01/2002 | WO2002010152A3 Novel indole derivatives and their use as medicaments |
| 08/01/2002 | WO2001078697A3 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists |
| 08/01/2002 | US20020103384 Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV |
| 08/01/2002 | US20020103379 Making 2,2-difluoro-2-(2-pyridyl)-ethan-1-ol, by coupling 2-bromopyridine with ethyl 2-bromo-2,2-difluoroacetate, using metallic copper and solvent; chemical intermediates |
| 08/01/2002 | US20020103378 Method for carbamoylating alcohols |
| 08/01/2002 | US20020103247 Indole and dihydroindole derivatives |
| 08/01/2002 | US20020103245 1-aryl or heteroaryl substituted 5-amino-4 carbonylpyrazole derivatives; antiinflammatory agents |
| 08/01/2002 | US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |
| 08/01/2002 | US20020103235 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 08/01/2002 | US20020103234 Heterocycl-containing carboxylic acid derivative and drug containing the same |
| 08/01/2002 | US20020103232 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 08/01/2002 | US20020103229 Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
| 08/01/2002 | US20020103227 Nitric oxide synthase inhibitors such as 6(4'-(4-phenethyl-piperazin-1-ylmethyl)-biphenyl-4-yl)-pyridin-2-ylamine for treatment and prevention of central nervous system disorders |
| 08/01/2002 | US20020103226 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 08/01/2002 | US20020103220 Such as N-(4-chlorobenzyl)-6-(4-morpholinylmethyl)-4-oxo-1-phenyl-1,4- dihydro-3-quinolinecarboxamide for treatment of herpes virus; viral DNA polymerase inhibitors |
| 08/01/2002 | US20020103214 Novel heteroaryl derivatives and their use as medicaments |
| 08/01/2002 | US20020103213 Pyrimidone compounds which are inhibitors of the enzyme Lp-PLA2; use in treating atheroscelerosis |
| 08/01/2002 | US20020103208 Useful in treatment of anxiety disorders, affective disorders such as depression, psychosis and schizophrenia, Parkinson's disease |
| 08/01/2002 | US20020103207 Tricyclic imine containing compounds having imidazole substituent; antitumor agents |
| 08/01/2002 | US20020103205 Muscarinic antagonists |
| 08/01/2002 | US20020103203 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis |
| 08/01/2002 | US20020103202 Heteroaryl-phenyl substituted factor Xa inhibitors |
| 08/01/2002 | US20020103201 Selective NPY (Y5) antagonists (triazines) |
| 08/01/2002 | US20020103198 Acylamino cyclopropane derivatives |
| 08/01/2002 | US20020103185 Pyrazole derivatives |
| 08/01/2002 | US20020103184 Cyclic malonamides as inhibitors of a beta protein production |
| 08/01/2002 | US20020102608 Library of indolinone compounds for use in the treatment of cancer |
| 08/01/2002 | US20020102597 Methods for selecting compounds for treating ischemia-related cellular damage |
| 08/01/2002 | CA2735478A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | CA2735267A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | CA2435883A1 Benzylamine analogue |
| 08/01/2002 | CA2434558A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 08/01/2002 | CA2433025A1 Substituted piperidines/piperazines as melanocortin receptor agonists |
| 08/01/2002 | CA2432985A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 08/01/2002 | CA2431996A1 Melanocortin receptor agonists |
| 08/01/2002 | CA2431904A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 07/31/2002 | EP1227093A2 Beta-lactams useful for preparation of taxanes having furyl or thienyl substituted side-chain |
| 07/31/2002 | EP1227092A2 Isonitrile intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties |
| 07/31/2002 | EP1227091A2 Formamide intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties |
| 07/31/2002 | EP1227090A1 Amine derivatives |
| 07/31/2002 | EP1227083A1 3-AMINOPIPERIDINE DERIVATIVES AS INTEGRIN $g(a)v$g(b)3 ANTAGONISTS |
| 07/31/2002 | EP1226141A1 Heterocyclic substituted pyrazolones |
| 07/31/2002 | EP1226139A2 Cyclized amide derivatives for treating or preventing neuronal damage |
| 07/31/2002 | EP1226138A1 Fab i inhibitors |
| 07/31/2002 | EP1226137A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/31/2002 | EP1226136A2 Tyrosine kinase inhibitors |
| 07/31/2002 | EP1226129A1 Methods and compositions utilizing quinazolinones |
| 07/31/2002 | EP1226126A1 Pyrimidine derivatives |
| 07/31/2002 | EP1226125A2 Method for producing therapeutic agents for ulcers |
| 07/31/2002 | EP1226123A1 Cyano compounds as factor xa inhibitors |
| 07/31/2002 | EP1226122A1 Bicyclic vasopressin agonists |
| 07/31/2002 | EP1226119A2 Tyrosine kinase inhibitors |
| 07/31/2002 | EP1226116A1 Processes for the preparation of sumatriptan and related compounds |
| 07/31/2002 | EP1225955A1 Aryl olefinic azacyclic, and aryl acetylenic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
| 07/31/2002 | EP1225894A1 Fab i inhibitors |
| 07/31/2002 | EP0958290B1 1,4-dihydropyridin derivatives and their use in therapy |
| 07/31/2002 | EP0880500B1 Esters of 3-hydroxy-piperidinemethanol derivatives |
| 07/31/2002 | EP0755930B1 Benzoxazepine derivatives, salts thereof, and drugs containing the same |
| 07/31/2002 | CN1361775A Novel diphenyl-piperidine derivate |
| 07/31/2002 | CN1361774A Heterocyclic substituted aminoazacycles useful as central nervous system agents |
| 07/31/2002 | CN1361773A Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 07/31/2002 | CN1361770A Heteroaromatic ring compounds |
| 07/31/2002 | CN1361769A Substituted 2-aryl-1,2,4-triazine-3,5-di(thi) one |
| 07/31/2002 | CN1361768A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 07/31/2002 | CN1361687A Phosphate transport inhibitors |
| 07/31/2002 | CN1361102A Method of producing imidacloprid |
| 07/31/2002 | CN1088477C Coloured fiber stabilized by hindered amine and ultraviolet absorbent synergistic mixture |
| 07/31/2002 | CN1088459C 1,4-disubstituted piperazines |
| 07/31/2002 | CN1088359C Medicine for curing cerebrovascular disturbance with psychonosema |
| 07/31/2002 | CA2369462A1 Nicotinamide acids, amides, and their mimetics active as inhibitors of pde4 isozymes |
| 07/30/2002 | US6426413 Inhibitors of caspases |
| 07/30/2002 | US6426360 Antiarthritic agents |
| 07/30/2002 | US6426354 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme |
| 07/30/2002 | US6426352 Inhibit the farnesylation of the oncogene protein ras; (+)-4-(3-bromo-8,10-dichloro-6,11-dihydro-5h-benzo(5,6)-cyclohepta(1,2 -b)pyridin-11-yl)-1-(methylsulfonyl)piperidine, for example |
| 07/30/2002 | US6426348 For therapy of inflammation associated with chronic inflammatory diseases such as rheumatoid arthritis (ra), multiple sclerosis, (ms), asthma, and inflammatory bowel disease (i bd) |
| 07/25/2002 | WO2002057422A2 Ternary biomolecule/polymer/surface-based immobilization systems |
| 07/25/2002 | WO2002057259A2 Pyrazole compounds useful as protein kinase inhibitors |
| 07/25/2002 | WO2002057258A1 Cyclo`d!azepane derivatives which are used as farnesyltransferase inhibitors and method for the preparation thereof |
| 07/25/2002 | WO2002057257A1 Cyclo`c!azepane derivatives which are used as farnesyltransferase inhibitors and method for the preparation therefor |
| 07/25/2002 | WO2002057255A1 4- or 5-substituted pyrrole derivatives |
| 07/25/2002 | WO2002057254A1 Compositions for prevention or treatment of hepatopathy |
| 07/25/2002 | WO2002057253A2 Isoindolyl and isoquinolinyl aroyl pyrrole compounds for the treatment of central nervous system disorders |
| 07/25/2002 | WO2002057240A1 Substituted triazole diamine derivatives as kinase inhibitors |
| 07/25/2002 | WO2002057236A1 Phenyl derivatives |
| 07/25/2002 | WO2002057233A1 Mch antagonists and their use in the treatment of obesity |
| 07/25/2002 | WO2002057223A2 Compounds azepane, preparation method therefor and pharmaceutical compositions containing said compounds |
| 07/25/2002 | WO2002056888A2 Assay method, tnf modulator and its use |
| 07/25/2002 | WO2002056884A2 Treatment of malaria with farnesyl protein transferase inhibitors |
| 07/25/2002 | WO2002056882A1 Quinolines and nitrogenated derivaive thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents |
| 07/25/2002 | WO2002050061A8 Piperazine derivatives for treatment of bacterial infections |
| 07/25/2002 | WO2002032874A3 Substituted heterocyclic compounds for treating multidrug resistance |
| 07/25/2002 | WO2002032422A3 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 07/25/2002 | WO2002014320A3 Novel substituted diaryl azepine derivatives as integrin ligands |
| 07/25/2002 | WO2002008177A3 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 07/25/2002 | WO2002006229A3 Heterocyclic beta-3 adrenergic receptor agonists |
| 07/25/2002 | WO2002002519A3 THROMBIN OR FACTOR Xa INHIBITORS |
| 07/25/2002 | WO2001070222A3 Compounds with 5-ht1a activity useful for treating disorders of the outer retina |